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3. Progress Report. (See Instructions) 
1. L. Gelbaum and L. H. Zalkow, "Secondary Plant Metabolites from Senecio smallii." 
30th Southeastern Regional Meeting, American Chemical Society, Savannah, Georgia 
Nov. 8-10, 1978. 
2. During the period covered, the following personnel devoted the indicated amounts 
of time. There will be no change except that Dr. H. Deutsch will not continue 
on this project. 
Dr. L. Gelbaum,Research Scientist, 100% time. 
Dr. H. Deutsch, Research Scientist, 25% time. 
Ms. S. Bonetti, B.S., technician, 50% time. 
3. During the period April 1, 1978 - Jan. 1, 1979, we have worked on the extracts 
from Senecio small-Li and Crotalaria spectablis. The extracts of these plants 
have been submitted for screening by the National Cancer Institute (NCI). 
Preliminary reports indicate that the 95% ethanol extract from S. smallii 
showed the activity indicated below: 




































2.7 X 10(1) 
The aqueous methanol partition from the plant further concentrated the active 
component as shown by the KB screen value of 2.8 X 10(0). Further separation 
and screening are in progress. 
By high performance liquid chromatography (HPLC) we have thus far isolated 
and determined the structures of the following compounds from S. smallii: 
ethyl-l-hydroxy•4-oxo-2,5-cyclohexadiene-l-acetate (1),14-oxo-1,2-dehydro-
cacalol methyl ether (2), and the pyrrolizidine alkaloids senecionine (3), 
senkirkine (4),and retrosine (5). Very efficient means have been developed 
for the separation of polar compounds such as pyrrolizidine alkaloids on 
reverse phase columns using HPLC and we have developed oneof the most efficient 
laboratories in the country for separation of natural products by HPLC. 
A large quantity of Crotolaria spectabilis seeds were collected in south 
Georgia and over 100 g of the pyrrolizidine alkaloid monocrotaline (6) was 
isolated from these seeds. Hydrolysis of this alkaloid, led in good yield to 
the -necine base retronecine (7) which is being used in the synthesis of semi-_ 
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3. (Continued) 
synthetic pyrrolizidine alkaloids. In this synthetic work it is anticipated that 
increased activity over the purely natural active pyrrolizidine alkaloids such as 
indicine N-oxide will be realized by a study of structure--activity relationships. 
During this period we have begun a compilation of "C NMR data on pyrrolizi-
dine alkaloids which allows rapid structural and stereochemical assignments. Like-
wise, we have utilized single crystal x-ray analysis routinely when suitable crystals 
were available and structures 2 and 7 were arrived at by this method. Figures I and 
II show the computer drawn structures of 2 and 7 respectively as arrived at from the 
x-ray data. 
During the next grant period we expect to continue work on the above mentioned 
plants and, in addition, we expect to initiate work on the following plants of the 

























The undersigned agrees to accept responsibility for the scientific and technical 
conduct of the project and for provision of required progress reports if a grant is 
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